Regulatory strategy
Initial assessment, device classification and development of the full approval roadmap in the country.
FDA
Register medical devices in the United States through 510(k), PMA or De Novo, with an English-language technical dossier and a dedicated U.S. Agent.
Speak to a specialistThe authority
A federal agency within the Department of Health and Human Services responsible for protecting public health by ensuring the safety and efficacy of medicines, food and medical devices.
Visit the official websiteRegulatory framework
| Class | Description | Examples |
|---|---|---|
| Class I | Low risk, general controls | Surgical gloves, gauze, stethoscopes |
| Class II | Moderate risk, generally requiring 510(k) | Infusion pumps, external pacemakers, X-ray equipment |
| Class III | High risk, requiring PMA and clinical studies | Heart valves, breast implants, internal pacemakers |
Registration process
Determine the risk class (I, II or III) using the FDA product code
Quality management system compliant with 21 CFR Part 820 (QMSR in 2026)
Prepare the 510(k), PMA or De Novo submission using the eSTAR electronic template
Appoint a representative in the USA (mandatory for foreign manufacturers)
510(k): 30-90 days for official review. PMA: 180 statutory days, in practice 9-36 months
Register the establishment with the FDA and complete annual device listing
Post-market
| Area | Requirement |
|---|---|
| Surveillance | MDR reporting through the FDA MAUDE database for adverse events and malfunctions |
| Renewal | Indefinite registration plus paid annual Establishment Registration |
| Required QMS | 21 CFR Part 820 (QMSR from February 2026, harmonising with ISO 13485) |
How HSC helps
Initial assessment, device classification and development of the full approval roadmap in the country.
Document preparation and translation in accordance with local requirements, including responses to deficiencies and requests.
Acting directly as legal representative or recommending an authorised partner accredited by the authority.
Monitoring regulatory changes, renewals, surveillance and responses to authority audits.
Frequently asked questions
Speak to our team for an initial assessment of your product and the most efficient regulatory pathway.
Speak to a specialist